The New York Times By Andrew Pollack January 27, 2016 The attorney general of Massachusetts said on Wednesday that she had opened an inquiry into whether Gilead Sciences had violated …
Corporate Welfare Fuels Gilead’s Record Q1 Profits
Gilead’s profits and earnings in first quarter of 2013 are tied to price increases on key AIDS drugs, and the evergreening of older drugs into the pricey new combination Stribild …
AIDS, Hepatitis C advocates protest Gilead at C.R.O.I.; also host drug-pricing forum
AIDS Healthcare Foundation (AHF), Citywide Project, and the HCV Coalition for the Cure will also co-host a community forum on fair drug pricing at Atlanta’s Phillip Rush Center to …
Gilead Q4 earnings release marks year of greed and price hikes, says AHF
Gilead’s profits and earnings in 2012 tied to price increases on key AIDS drugs, and the “evergreening” of older drugs into the pricey new combination Stribild, the most expensive …
Gilead blasted for price hikes on four key AIDS drugs
A recent Cowen Quick Take Distribution investor advisory notes ‘third party sources’ report that on January 1st, Gilead raised its prices on eight drugs, including four key AIDS medications, …
Gilead Sciences Faces Pressure to Keep Price Low on New HIV Drug
By: Peter Loftus Dow Jones News Wires August 22, 2012 Gilead Sciences Inc. (GILD) may get clearance by next week to sell what is expected to become a blockbuster HIV …
FDA favors first drug for HIV prevention
Outlet: Associated Press By Matthew Perrone Date: May 8, 2012 WASHINGTON – Federal drug regulators on Tuesday affirmed landmark study results showing that a popular HIV-fighting pill can also help …
HIV pill for prevention debated as FDA ruling nears
By Deena Beasley Reuters An advocacy group concerned about costs and possible health problems related to a drug being considered to help stop the spread of HIV infection to healthy …
AHF Blasts Gilead for Squeezing Every Last Cent Out of Truvada
AHF advocacy campaign, which targets San Francisco and San Mateo County neighborhoods of Gilead’s Foster City headquarters, seeks to educate company employees and general public about Gilead’s seeming rush for …
AHF Slams Gilead “HIV Prevention Pill” FDA Application
Despite failed results from numerous clinical trials of Gilead’s HIV/AIDS drug Truvada as an HIV prevention pill (pre-exposure prophylaxis or PrEP), the drug company recently submitted an application to the …
